Topic

Catheters


FDA, Teleflex issue recalls for Arrow tubing sets, catheters

Regulatory News | Wednesday, March 17 2010
 

i2 Meet the Experts: Transradial Access and Intervention Case Reviews

Previews | Wednesday, March 10 2010
 

Pathway nets CE Mark for peripheral atherectomy catheter

Regulatory News | Tuesday, December 15 2009
 

Medtronic completes Ablation Frontiers acquisition

Mergers & Acquisitions | Sunday, February 08 2009
 

FDA, EU clear 3 Avalon catheters

Regulatory News | Wednesday, January 21 2009
 

FDA clears Ascent reprocessed EP catheters, cables

Regulatory News | Wednesday, October 29 2008
 

FDA issues recall for Baylis guiding sheaths

Regulatory News | Friday, March 12 2010
 

HealthTrust Purchasing, Zoll ink deal for temperature management system

Contracts & Installations | Friday, January 29 2010
 

Invatec receives 510(k) clearance for below-the-knee long balloon

Regulatory News | Thursday, April 02 2009
 

FDA clears Insightra IAB catheters

Regulatory News | Thursday, January 29 2009
 

Philips, Hansen integrate x-ray, robotic catheter for cardiac arrhythmias

Partnerships & Alliances | Wednesday, January 14 2009
 


Web Exclusives

Commentary: Atrial fibrillation strikes an electrophysiologist

 Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.

AHRQ: Health IT could be disruptive while reducing rehospitalization rates, costs

 The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).

New patient monitoring model draws scrutiny

 A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.

Commentary: Overcoming challenges with drug-eluting stents

 There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.